Works matching DE "NEUROFIBROMATOSIS 2"
Results: 380
Ocular alterations, molecular findings, and three novel pathological mutations in a series of NF2 patients.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2019, v. 257, n. 7, p. 1453, doi. 10.1007/s00417-019-04348-5
- By:
- Publication type:
- Article
Sporadic pediatric vestibular schwannoma: a case report in a 4-year-old boy.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 7, p. 2251, doi. 10.1007/s00381-024-06398-5
- By:
- Publication type:
- Article
Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 6, p. 1821, doi. 10.1007/s00381-024-06325-8
- By:
- Publication type:
- Article
Sporadic vestibular schwannoma in a pediatric population: a case series.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 3, p. 635, doi. 10.1007/s00381-023-06184-9
- By:
- Publication type:
- Article
Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease.
- Published in:
- Child's Nervous System, 2023, v. 39, n. 10, p. 2791, doi. 10.1007/s00381-023-06160-3
- By:
- Publication type:
- Article
Multiple craniospinal tumors in a pediatric patient with neurofibromatosis type 2: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Pediatric vestibular schwannoma without evidence of neurofibromatosis: consecutive 18 microsurgical experiences.
- Published in:
- Child's Nervous System, 2022, v. 38, n. 8, p. 1505, doi. 10.1007/s00381-022-05477-9
- By:
- Publication type:
- Article
Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 6, p. 857, doi. 10.1007/s00401-023-02641-6
- By:
- Publication type:
- Article
Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 5, p. 1053, doi. 10.1007/s00401-022-02474-9
- By:
- Publication type:
- Article
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype.
- Published in:
- Acta Neuropathologica, 2021, v. 141, n. 6, p. 971, doi. 10.1007/s00401-021-02304-4
- By:
- Publication type:
- Article
Correction to: An update on the CNS manifestations of neurofibromatosis type 2.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
An update on the CNS manifestations of neurofibromatosis type 2.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 4, p. 643, doi. 10.1007/s00401-019-02029-5
- By:
- Publication type:
- Article
Cochlear Implantation in a Patient with Neurofibromatosis Type 2 and an Intracochlear Schwannoma: A Case Report and Literature Review.
- Published in:
- ORL, 2022, v. 84, n. 5, p. 425, doi. 10.1159/000522473
- By:
- Publication type:
- Article
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 257, doi. 10.1007/s40487-024-00279-2
- By:
- Publication type:
- Article
Psychiatric symptoms in neurofibromatosis type 2.
- Published in:
- European Psychiatry, 2021, v. 64, p. S238, doi. 10.1192/j.eurpsy.2021.637
- By:
- Publication type:
- Article
Merlin casts its spell on the cortical cytoskeleton.
- Published in:
- Journal of Cell Biology, 2015, v. 211, n. 2, p. 207, doi. 10.1083/jcb.2112if
- By:
- Publication type:
- Article
NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.
- Published in:
- Journal of Cell Biology, 2015, v. 211, n. 2, p. 391, doi. 10.1083/jcb.201503081
- By:
- Publication type:
- Article
How calm should I keep? Café-au-lait macules as potential manifestations of cancer susceptibility syndromes.
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 33
- By:
- Publication type:
- Article
Combined mTOR/MEK inhibition prevents proliferation and induces apoptosis in NF2-mutant tumors.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2019, v. 23, n. 13, p. 5874
- By:
- Publication type:
- Article
Bevacizumab in Neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation.
- Published in:
- Neuro-Oncology Practice, 2016, v. 3, n. 4, p. 281, doi. 10.1093/nop/npv065
- By:
- Publication type:
- Article
Differences Between the Two Most Common Forms of Neurofibromatosis and the Importance of their Exact Diagnosis- a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Cochlear implantation in patients suffering from Neurofibromatosis type 2.
- Published in:
- Journal of Hearing Science, 2018, v. 8, n. 2, p. 327
- By:
- Publication type:
- Article
A 29-year-old female with Neurofibromatosis type II who underwent auditory brainstem implantation.
- Published in:
- Journal of Hearing Science, 2018, v. 8, n. 2, p. 299
- By:
- Publication type:
- Article
Cochlear implants in patients with neurofibromatosis type 2.
- Published in:
- Journal of Hearing Science, 2018, v. 8, n. 2, p. 71
- By:
- Publication type:
- Article
Binaural benefit after sequential bilateral auditory brainstem implantation.
- Published in:
- Journal of Hearing Science, 2018, v. 8, n. 2, p. 70
- By:
- Publication type:
- Article
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
- Published in:
- Nature Communications, 2023, p. 1, doi. 10.1038/s41467-023-37226-0
- By:
- Publication type:
- Article
SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Differences in merlin and p53 expression as a predisposing factor in orbital meningioma.
- Published in:
- Journal of Neurosciences in Rural Practice, 2024, v. 15, n. 3, p. 477, doi. 10.25259/JNRP_642_2023
- By:
- Publication type:
- Article
Expert commentary on rare (nonvestibular, nontrigenimal) cranial nerve schwannomas.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0305121
- By:
- Publication type:
- Article
Multiple CNS Tumors in a Patient With Neurofibromatosis Type 2: Classical Presentation of a Rare Disease.
- Published in:
- Acta Medica Iranica, 2020, v. 58, n. 7, p. 362
- By:
- Publication type:
- Article
'This diagnosis can be extremely scary'.
- Published in:
- Nursing Standard, 2017, v. 31, n. 21, p. 22, doi. 10.7748/ns.31.21.22.s24
- By:
- Publication type:
- Article
Clinical severity grading of NF2-related schwannomatosis.
- Published in:
- Orphanet Journal of Rare Diseases, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13023-024-03512-3
- By:
- Publication type:
- Article
Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis.
- Published in:
- American Journal of Clinical Pathology, 2024, v. 162, n. 2, p. 110, doi. 10.1093/ajcp/aqae027
- By:
- Publication type:
- Article
Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12814, doi. 10.3390/ijms241612814
- By:
- Publication type:
- Article
Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 10017, doi. 10.3390/ijms231710017
- By:
- Publication type:
- Article
CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8616, doi. 10.3390/ijms23158616
- By:
- Publication type:
- Article
A Critical Overview of Targeted Therapies for Vestibular Schwannoma.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5850, doi. 10.3390/ijms22115850
- By:
- Publication type:
- Article
Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 690, doi. 10.3390/ijms22020690
- By:
- Publication type:
- Article
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 4, p. 988, doi. 10.3390/ijms19040988
- By:
- Publication type:
- Article
Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Magnetically controlled growing rods in early onset scoliosis: radiological results, outcome, and complications in a series of 22 patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Search for Chemical Compounds for Pharmacotherapy of Neurofibromatosis Type 2.
- Published in:
- Pharmaceutical Chemistry Journal, 2015, v. 48, n. 12, p. 777, doi. 10.1007/s11094-015-1194-z
- By:
- Publication type:
- Article
CO-OCCURRENCE OF SCHWANNOMA AND MENINGIOMA: IMPLICATIONS FOR NEUROFIBROMATOSIS TYPE 2 DIAGNOSIS.
- Published in:
- Acta Marisiensis. Seria Medica, 2024, v. 70, p. 269
- By:
- Publication type:
- Article
Phacomatoses, genetic testing for personalisation of clinical management (part 1.).
- Published in:
- Nowotwory, 2021, v. 71, n. 6, p. 420, doi. 10.5603/NJO.2021.0075
- By:
- Publication type:
- Article
Bevacizumab for Vestibular Schwannomas in Neurofibromatosis Type 2: A Systematic Review of Tumor Control and Hearing Preservation.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7488, doi. 10.3390/jcm13237488
- By:
- Publication type:
- Article
First Clinical Experience with a New Device for the Removal of Cochlear Schwannomas.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 11, p. 3300, doi. 10.3390/jcm13113300
- By:
- Publication type:
- Article
Audiological Outcome of the Simultaneous Tumor Resection and Cochlear Implantation in Two Cases of Sporadic and Two Cases of Neurofibromatosis Type 2-Associated Intracochlear Schwannoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 11, p. 3042, doi. 10.3390/jcm13113042
- By:
- Publication type:
- Article
Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 7, p. 1508, doi. 10.1002/acn3.51386
- By:
- Publication type:
- Article